Slowing Down Matters More Than We Think GLP-1 isnt influenced only by what we eat
Making the right decision about weight loss, whether through lifestyle change or medical support, starts with expert evaluation
The first is the GLP-1 receptor , which most people recognize from semaglutide and other incretin-based therapies
This can cause pain, numbness, and other complications that may require medical attention
In contrast, the FAT domain scaffold forms critical interactions with focal adhesion proteins and oncogenic receptor tyrosine kinases, mediating multiple signaling cascades for tumorigenesis, providing a potentially safe and effective therapeutic advantage over traditional kinase inhibition (Supplementary Fig
GLP-1 RAs have been found to improve body weight, blood pressure (BP), lipid profile levels, and myocardial infarction (MI) outcomes even in nondiabetic patients without increasing the risk of hypoglycemic events ( Our narrative review aimed to discuss the CV benefits of GLP-1 RAs in terms of controlling CV risk factors and improving HF outcomes, and the CV perspectives related to their use in clinical practice